CDC logoSafer Healthier People  CDC HomeCDC SearchCDC Health Topics A-Z
NIOSH - National Institute for Occupational Safety and Health

Skip navigation links Search NIOSH  |  NIOSH Home  |  NIOSH Topics  |  Site Index  |  Databases and Information Resources  |  NIOSH Products  |  Contact Us

NIOSH Respiratory Diseases Research Program

Evidence Package for the National Academies' Review 2006-2007

Appendix List - Chapter 7

previous Appendix List - Chapter 6 | Appendix List - Chapter 8 next


RDRP contribution to: Strategic Plan for NIOSH Nanotechnology Research Filling the Knowledge Gaps Draft September 28, 2005 Nanotechnology Research Program National Institute for Occupational Safety and Health Centers for Disease Control and Prevention


RDRP contribution to: NIOSH Safety and Health Topic: Nanotechnology Approaches to Safe Nanotechnology: An Information Exchange with NIOSH 9/6/2006 (Link updated 12/16/2009 -


RDRP contribution to: Nanotechnology Nanoparticle Information Library (NIL)  9/6/2006


RDRP contribution to: NIOSH Safety and Health Topic:Nanotechnology NIOSH, Nanotechnology, and Occupational Safety and Health Research - Frequently Asked Questions 9/6/2006


List of nanotechnology publications (75)


List of nanotechnology presentations at professional conferences (177)


Shvedova AA. Kisin ER. Mercer R. Murray AR. Johnson VJ. Potapovich AI. Tyurina YY. Gorelik O. Arepalli S. Schwegler-Berry D. Hubbs AF. Antonini J. Evans DE. Ku BK. Ramsey D. Maynard A. Kagan VE. Castranova V. Baron P. Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. American Journal of Physiology - Lung Cellular & Molecular Physiology. 289:L698-708, 2005.


Oberdorster G., A. Maynard, K. Donaldson, V. Castranova, J. Fitzpatrick, K. Ausman, J. Carter, B. Karn, W. Kreyling, D. Lai, S. Olin, N. Monterio-Riviere, D. Warheit, and H. Yang.  Principles for characterizing the potential human effects from exposure to nanomaterials:  elements of screening strategy.  Particle and Fibre Toxicol 2:8, 2005.


RDRP Nanotechnology Partnership and Collaboration Examples


Congressional testimony of Altairnano CEO Alan Gotcher